Loading...
Loading...
Application UK00915968779 · Registered

| Application Number | UK00915968779 |
| Status | Registered |
| Owner | Saisei Mirai Clinic |
| Filed | 2016-10-25 |
| Registered | 2017-03-27 |
| Renewal Due | 2026-10-25 |
| Type | Individual |
| Feature | Figurative |
| Attorney | See claim section below |
Yes. SAISEI Colostrum MAF is currently a registered UK trademark, with renewal due on 2026-10-25. It is protected under UK intellectual property law and can be enforced against infringing uses.
Colour Claimed : Black; Orange; Lime Green; Green.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Pharmaceutical preparations and substances for the treatment of cancer, autism, chronic fatigue syndrome (CFS), Lyme disease, infection, influenza, norovirus, malaria, dengue fever, human immunodeficiency virus (HIV), hepatitis B and C, tuberculosis, autoimmune disease, alopecia and atopic dermatitis; dietary and nutritional supplements for humans.
This figurative mark is indexed under the following Vienna categories by the UK IPO:
'SAISEI Colostrum MAF' is a registered trademark on the UK IPO register, owned by Saisei Mirai Clinic. The application (UK00915968779) was filed on 25 October 2016 and registered on 27 March 2017. The registration is set to expire on 25 October 2026.
This mark is recorded under Class 5 (pharmaceuticals & medical preparations), specifically covering: Colour Claimed : Black; Orange; Lime Green; Green.
The trademark is represented by BECKORD & NIEDLICH PATENTANWÄLTE PARTG MBB.
UK trademark UK00915968779 for the mark 'SAISEI Colostrum MAF' in Class 5 is recorded on the UK IPO register as owned by Saisei Mirai Clinic. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Yes — the UK IPO records UK trademark UK00915968779 for the mark 'SAISEI Colostrum MAF' as registered.
UK trademark UK00915968779 for the mark 'SAISEI Colostrum MAF' is registered in Class 5 (pharmaceuticals & medical preparations). The filed specification reads: Class 5: Pharmaceutical preparations and substances for the treatment of cancer, autism, chronic fatigue syndrome (CFS), Lyme disease, infection, influenza, norovirus, malaria, dengue fever, human immunodeficiency virus (HIV), hepatitis B and C, tuberculosis, autoimmune disease, alopecia and atopic dermatitis; dieta…
UK trademark UK00915968779 for the mark 'SAISEI Colostrum MAF' was filed at the UK IPO on 25 October 2016 and registered on 27 March 2017.
UK trademark UK00915968779 for the mark 'SAISEI Colostrum MAF' is currently recorded as valid until 25 October 2026, at which point it will need to be renewed with the UK IPO to remain in force.
BECKORD & NIEDLICH PATENTANWÄLTE PARTG MBB is listed as the attorney / representative of record for UK trademark UK00915968779 for the mark 'SAISEI Colostrum MAF' on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.